FDA Inspection 1147262 — OneBlood, Inc.

OneBlood, Inc. — FEI 1072542

The FDA completed an inspection of OneBlood, Inc. on Jul 20, 2021 in Tallahassee, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jul 20, 2021
Fiscal Year
2021
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Tallahassee, FL (United States)

Citations

IDCFRDescription
442521 CFR 606.60(a)Equipment observed, standardized, calibrated

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.